| Ulrika Rae Eldridge, CCC-SLP | |
|
656 Dillon Way, Aurora, CO 80011-6803 | |
| (303) 344-0636 | |
| Not Available |
| Full Name | Ulrika Rae Eldridge |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 656 Dillon Way, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215797485 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | PSLP.0001138 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ulrika Rae Eldridge, CCC-SLP 5302 S Broadway Cir Apt 2-303, Englewood, CO 80113-6724 Ph: (720) 766-7407 | Ulrika Rae Eldridge, CCC-SLP 656 Dillon Way, Aurora, CO 80011-6803 Ph: (303) 344-0636 |
News Archive
A rare, small RNA turns a gene-splicing machine into a switch that controls the expression of hundreds of human genes. Howard Hughes Medical Institute Investigator and professor of Biochemistry Gideon Dreyfuss, PhD, and his team from the Perelman School of Medicine at the University of Pennsylvania, discovered an entirely new aspect of the gene-splicing process that produces messenger RNA (mRNA).
Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF)as a treatment for Parkinson's disease.
Within the "umbrella" of rare diseases, rare cancer patients confront particular problems. Most rare diseases have an identified genetic origin. In contrast, rare cancers are mainly acquired diseases.
LSE Health at the London School of Economics and Political Science is leading a consortium of 15 institutional partners awarded $4.59 million Euros by the European Commission under the Horizon2020 Framework Programme for a new 3-year project entitled IMPACT HTA (Health Technology Assessment), commencing in January 2018.
Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia (higher than normal potassium levels). The study appears in JAMA and is being released to coincide with its presentation at the American Heart Association's Scientific Sessions 2014.
› Verified 7 days ago
Miss Elizabeth Frances Peterson, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 S Parker Rd Ste 336, Aurora, CO 80014 Phone: 303-330-3309 Fax: 303-862-9770 | |
Rebecca Aragon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Kristina Hess, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 500 Geneva St, Aurora, CO 80010 Phone: 303-364-9311 | |
Elizabeth Marie Cuadrado, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1635 Aurora Court, 6th Floor, Ms F737, Aurora, CO 80045 Phone: 954-735-6000 | |
Cheryl Anselmo, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Box 030, Aurora, CO 80045 Phone: 720-777-6085 | |
Mrs. Melanie Lynn Wiseman, M.S. SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 2851 S Parker Rd Ste 570, Aurora, CO 80014 Phone: 303-888-4840 | |
Chloe Mizusawa, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10100 E 13th Ave, Aurora, CO 80010 Phone: 303-366-2671 |